Overview: Biologicals & Immunologicals: Novel drug delivery systems

References

• Novel drug delivery systems. (1992). CHIEN YW (Ed.) Marcel Dekker, New York
   Google Scholar
• a.Ref 1; Chapters 1–2
   Google Scholar
• b.Ref 1; Chapters 8
   Google Scholar
• LANGER R: Polymer-controlled drug delivery systems. Accounts of Chem. Res. (1993) 26: 10537–542.
   Google Scholar
• MASTERS DB, BERDE CB, DUTTA S, TUREK T, LANGER R: Sustained local anaesthetic release from bioerodible polymer matrices - a potential method for prolonged regional anaesthesia. Pharm. Res. (1993) 10: 1527–1532
   PubMed Web of Science ®Google Scholar
• CONTE U, MAGGI L, COLOMBO P, LAMANNA A: Multi-lay-ered hydrophilic matrices as constant release devices (Geomatrix (ins) systems). J. Control. Rel. (1993) 26: 39–47
   Web of Science ®Google Scholar
• CONTE U, MAGGI L, TORRE ML, GIUNCHEDI P, LAMANNAA: Press-coated tablets for time-programmed release of drugs. Biomaterials (1993) 14: 1017–1023
   PubMed Web of Science ®Google Scholar
• YUEN ICH, DESHMUKH AA, NEWTON JM, SHORT M, MELCHOR R: Gastrointestinal transit and absorption of theophylline from a multiparticulate controlled release formulation. Intern. J. Pharm. (1993) 97: 61–77
   Google Scholar
• HOSNY EA: Polycarbophil as a controlled release ma-trix. Intern.J. Pharm. (1993) 98: 235–238
   Web of Science ®Google Scholar
• PEPPAS NA, ICHARE AR: Preparation, structure and diffusional behavior of hydrogels in controlled release. Adv. Drug Del. Rev. (1993) 11: 1–35.
   Web of Science ®Google Scholar
• BAE YH, KIM SW HYDROGEL: Delivery systems based on polymer blends, block co-polymers or interpenetrating networks. Adv. Drug Del. Rev. (1993) 11: 109–135.
   Web of Science ®Google Scholar
• LUNDBORG P, ABRAHAMSSON B, WIESELGREN I, WAL-TER M: The pharmacokinetics and pharmacodynamirs of metoprolol after conventional and controlled-re-lease administration in combination with hydrochlo-rothla7kif. in healthy volunteers. Eur.J. Clin. Pharrnacol. (1993) 45: 161–163
   PubMedGoogle Scholar
• TOMIDA H, MIZUO C, NAKAMURA C, KIRYU S: Imi-pramine release from Ca-Alginate gel beads. Chem. & Pharm. Bull. (1993) 41: 1475–1477
   Web of Science ®Google Scholar
• MOCICEL JE, LIPPOLD BC: Zero-order drug release fromhydrocolloid matrices. Pharm. Res. (1993) 10: 1066–1070
   PubMedGoogle Scholar
• OKUYAMA Y, YOSHIDA R, SAKAI K, OKANO T, SAICURAIY: Swelling controlled zero order and sigmoidal drug release from thermo-responsive poly(N-isopropylacry-lamide-co-butyl methacrylate) hydrogeL j Biomaterials Sci. - Polymer Edition (1993) 4: 545–556
   Google Scholar
• GIUNCHEDI P, MAGGI L, CONTE U, LAMANNA A: Linearextended release of a water-insoluble drug, car-bamazepine, from erodible matrices. Intern. J. Pharm. (1993) 94: 15–22
   Web of Science ®Google Scholar
• FUJI M, HIOKI M, NISHI M, HENMI T, NAKAO M,SHIOZAWA K, MATSUMOTO M: Preparation of the solid dispersion of indomethacin with phosphatidylcholine by heating method. Chem. & Pharm. Bull. (1993) 41: 1275–1278
   Google Scholar
• AKIYAMA Y, YOSHIOKA M, HORIBE H, HIRAI S, KITAMORIN, TOGUCHI H: Novel oral controlled-release micro-spheres using polyglycerol esters of fatty acids. J. Con-trol. Rel (1993) 26: 1–10
   Web of Science ®Google Scholar
• AICIYAMA Y, YOSHIOKA M, HORIBE H, HIRAI S, KITAMORIN, TOGUCHI H: Mechanism of drug release from poly-glycerol ester of fatty acid-based microspheres. J. Con-trol. Rel (1993) 27: 37–45
   Google Scholar
• CARABALLO I, FERNANDEZAREVALO M, HOLGADO MA,RABASCO AM: Percolation theory - application to the study of the release behaviour from inert matrix sys-tems. Mtern. J. Pharm. (1993) 96: 175–181
   Google Scholar
• ELSHANAWANY S: Sustained release of nitrofurantoinfrom inert wax matrixes. J. Control. Rel. (1993) 26: 11–19
   Google Scholar
• DAVIS SS, WILDING EA, WILDING IR: Gastrointestinal tran-sit of a matrix tablet formulation - comparison of canine and human data. Intern. J. Pharm. (1993) 94: 235–238
   Web of Science ®Google Scholar
• PAPADIMITRIOU E, BUCKTON G, EFENTAKLS M: Probing the mechanisms of swelling of hydroxypropylmethyl-cellulose matrices. Intern. J. Pharm. (1993) 98: 57–62
   Web of Science ®Google Scholar
• COLOMBO P: Swelling-controlled release in hydrogel matrices for oral route. Adv. Drug Del. Rev. (1993) 11: 37–57 Review
   Google Scholar
• KRISTL J, SMIDKORBAR J, STRUC E, SCHARA M, RUP-PRECHT H: Hydrocolloids and gels of chitosan as drug carriers. Intern.' Pharm. (1993) 99: 13–19
   Web of Science ®Google Scholar
• VANDELLI MA, CAMERONI R: Selective coating of cylin-drical matrices with a central hole .1. An interpretation of the swelling process. Intern. J. Pharm. (1993) 100: 107–114
   Google Scholar
• VANDELLI MA, COPPI G, CAMERONI R: Selective coatingof cylindrical matrices with a central hole.2. An inter-pretation of the release process. Intern . J. Pharm. (1993) 100: 115–121
   Google Scholar
• GROSSER AE, FITZSIMONS M, LEONARDI L, SALHA J: Model for a controlled-release drug delivery safety system with permeable and erodible coatings. J. Pharm. Sc( (1993) 82: 1061–1063
   PubMedGoogle Scholar
• CARELLI V, DICOLO G, NANNIPIERI E, SERAFINI MF: Astudy of controlled-release systems for progesterone based on crosslinked poly(ethylene oxides). Intern. J. Pharm. (1993) 94: 103–113
   Google Scholar
• LEUNG SHS, IRONS BK, ROBINSON JR: Polyanionic hy-drogel as a gastric retentive system. J. Biomaterials Sci. - Polymer Edition (1993) 4: 483–492
   PubMedGoogle Scholar
• LEE PI: Constant-rate drug release from novel anionicgel beads with transient composite structure. J. Pharm. Sci. (1993) 82: 964–967
   PubMedGoogle Scholar
• MCNEILL ME, GRAHAM NB: Properties controlling thediffusion and release of water-soluble solutes from poly(ethylene oxide) hydrogels.2. Dispersion in an Initially dry slab. J. Biomaterials Sci. - Polymer Edition (1993) 5: 111–130
   PubMed Web of Science ®Google Scholar
• HARLAND RS, PEPPAS NA: Hydrophilic/Hydrophobic, block and graft copolymeric hydrogels - synthesis, characterization, and solute partition and penetration. J. Control. Rel. (1993) 26: 157–174
   Web of Science ®Google Scholar
• THACHARODI D, RAO ICP: Release of nffedipine throughcrosslinked chitosan membranes. Intern. J. Pharm. (1993) 96: 33–39
   Web of Science ®Google Scholar
• KNUTH K, AMIJI M, ROBINSON JR: Hydrogel delivery systems for vaginal and oral applications - formulation and biological considerations. Adv. Drug Del. Rev. (1993) 11: 137–167.
   Web of Science ®Google Scholar
• ANDRIANOV AK, COHEN S, VISSCHER KB, PAYNE LG, ALLCOCK HR, LANGER R: Controlled release using ionot-ropic polyphosphazene hydrogels. J. Control. Rel (1993) 27: 69–77
   Google Scholar
• SAWHNEY AS, PATHAK CP, HUBBELL JA: Interfacial pho-topolymerization of poly(ethylene glycol)-based hy-drogels upon alginate poly(L-lysine) microcapsules for enhanced biocompatibility. Biomaterials (1993) 14: 1008–1016
   PubMed Web of Science ®Google Scholar
• GARCIAGONZALEZ N, KELLAWAY IW, BLANCOFUENTE H,ANGUIANOIGEA S, DELGADOCHARRO B, OTEROESPINAR FJ, BLANCOMENDEZ J: Influence of beta-cyclodextrin concentration and polyacrylic add molecular weight on swelling and release characteristics of metodo-pramide-containing hydrogels. Intern. J. Pharm. (1993) 100: 25–31
   Google Scholar
• GARCIAGONZALEZ N, ICELLAWAY IW, BLANCOFUENTE H,ANGUIANOIGEA S, DELGADOCHARRO B, OTEROESPINAR FJ, BLANCOMENDEZ J: Design and evaluation of bucco-adhesive metoclopramkle hydrogels composed of poly(acrylic add) crosslinked with sucrose. Intern. J. Mann. (1993) 100: 65–70
   Google Scholar
• SHAH N, ZHANG GH, APELIAN V, ZENG FW, INFELD MH,MALICK AW: Prediction of drug release from by-droxypropyl methylcellulose (hpmc) matrices - effect of polymer concentration. Pharm. Res. (1993) 10: 1693–1695
   PubMed Web of Science ®Google Scholar
• SINGH R, AWASTHI S, WAS SP: New development onhydrogels -potential in drug delivery. Pharmazie (1993) 48: 728–731
   Web of Science ®Google Scholar
• JALIL R, FERDOUS AJ: Effect of viscosity increasing agentand electrolyte concentration on the release rate of theophylline from a hpmc based sustained release capsules. Drug Dev. Ind. Pharm. (1993) 19: 2637–2643
   Web of Science ®Google Scholar
• DAVIDSON R, NYQVIST H, RAGNARSSON G: Porous cellulose matrices - a novel excipient for the formula-tion of solid dosage forms. Intern. J. Pharm. (1993) 100: 49–54
   Google Scholar
• FERNANDEZAREVALO M, HOLGADOV1LLAFUERTE MA, GINESDORADO JM, RABASCOALVAREZ AM: Effects of different fillers and wetting liquids on the dissolution behavior of carteolol hydrochloride controlled release Inert matrix tablets. Intern. J. Pharm. (1993) 95: 117–125
   Google Scholar
• AOKI S, ANDO H, MACHIDA R, IDA K, WATANABE S, OZAWA H: Sustained-release matrix using hy-droxypropylcellulose ethylcellulose complex as a filler, and controlling factors of drug release. Chem. & Pbarrn. Bull. (1993) 41: 1438–1443
   Web of Science ®Google Scholar
• OSTBERG T, VESTERHUS L, GRAFFNER C: Calcium algi-nate matrices for oral multiple unit administration .2. Effect of process and formulation factors on matrix properties. Intern. J. Pharm. (1993) 97: 183–193
   Google Scholar
• RUBINO OP, KONWALSICY R, SWARBRICK J: Albumin mi-crospheres as a drug delivery system - relation among turbidity ratio, degree of cross-linking, and drug re-lease. Pharm. Res. (1993) 10: 1059–1065
   PubMed Web of Science ®Google Scholar
• DORTA MJ, MUNGUIA O, LLABRES M: Effects of polym-erization variables on plgo properties - molecular weight, composition and chain structure. Intern. J. Pharm. (1993) 100: 9–14
   Web of Science ®Google Scholar
• MITCHELL K, FORD JL, ARMSTRONG DJ, ELLIOTT PNC, HOGAN JE, ROSTRON C: The influence of substitution type on the performance of methylcellulose and hy-droxypropylmethycelhtlose in gels and matrices. In-tern. J. Pharm. (1993) 100: 143–154
   Google Scholar
• SIVIN I: International experience with Norplant and Norplant 2 contraceptives. Studies in Family Planning (1988) 19: 81–94
   PubMed Web of Science ®Google Scholar
• COHEN PE, MILLIGAN SR: Silastic implants for delivery of oestradiol to mice. J. Reprod. Fert. (1993)99: 219–223
   PubMedGoogle Scholar
• SATO J, YOROZUYA H, SUNAMOTO M, TUKAMOTO K: Pharmaceutical characterization of silicone elastomer Implant system containing chlormadinone acetate for prevention of oestrus in bitches. YakugakuZasshi Pharm. Soc. Japan (1993) 113: 705–711. (Japanese)
   Google Scholar
• FIX JA, CARGILL R, ENGLE K: Controlled gastric empty-ing.3. Gastric residence time of a nondisintegrating geometric shape in human volunteers. Pharm. Res. (1993) 10: 1087–1089
   Google Scholar
• CHARRUEAU C, ARNAUD P, DURIEUX J, ALLAIN J, CHAUMELL JC: Oropharyngeal decontamination - bioad-hesive powder mixture formulation.l. Choice of the bioadhesive material. J. Control. Rel (1993) 26: 49–57
   Web of Science ®Google Scholar
• HELLIWELL M: The use of bioadhesives in targeted deifyery within the gastrointestinal tract. Adv. Drug Del. Rev. (1993) 11: 221–251.
   Web of Science ®Google Scholar
• SMART JD: Drug delivery using buccal-adhesive systems Adv. Drug Del. Rev. (1993) 11: 3
   Google Scholar
• LENAERTS V, GURNY R: Bioadhesive drug delivery sys-tems. CRC Press Inc Florida 1990
   Google Scholar
• a. MIKOS AG, PEPPAS NA: Ref 55; Chapter 2
   Google Scholar
• b. GUPTA PK, LEUNG SHS, ROBINSON JR: Ref 55; Chapter 4
   Google Scholar
• JABBARI E, WISNIEWSKI N, PEPPAS NA: Evidence of mucoadhesion by chain interpenetration at a poly(acrylic acid)/mucin interface using ATR-FT1R spectroscopy. J. Control. Rel. (1993) 26: 99–108
   Web of Science ®Google Scholar
• MORTAZAVI SA, CARPENTER BG, SMART JD: A compara-tive study on the role played by mucus glycoproteins in the theological behaviour of the mucoadhesive/rau-cosal Interface. Intern. J. Pharm. (1993) 94: 195–201
   Web of Science ®Google Scholar
• LANSLEY AB: Mucociliary clearance and drug delivery via the respiratory tract Adv. Drug Del. Rev. (1993) 11: 299–327
   Web of Science ®Google Scholar
• KARLSSON J, WIKMAN A, ARTURSSON P: The mucus layeras a barrier to drug absorption in monolayers of human Intestinal epitheliallIT29-H goblet cells. Intern .J. Ph arm. (1993) 99: 209–218
   Google Scholar
• MACADAM A: The effect of gastro-intestinal mucus ondrug absorption. Adv. Drug Del. Rev. (1993) 11:201-220 Review
   Google Scholar
• LAWRENSON JG, EDGAR DF, GUDGEON AC, BURNS JM, GERAINT M, BARNARD NAS: A comparison of the effi-cacy and duration of action of topically applied proxymetacaine using a novel ophthalmic delivery system versus eye drops in healthy young volunteers. Brit. J. Ophthalmol (1993) 77: 713–715
   PubMed Web of Science ®Google Scholar
• GREAVES JL, WILSON CG: Treatment of diseases of the eye with mucoadhesive delivery systems. Adv. Drug del Rev. (1993) 11: 349–383
   Web of Science ®Google Scholar
• SANZGIRI YD, MASCHI S, CRESCENZI V, CALLEGARO L, TOPP EM, STELLA VJ: Gellan-based systems for ophthal-ink sustained delivery of methylprednisolone. J. Con-trol. Rel. (1993) 26: 195–201.
   Web of Science ®Google Scholar
• BRANNON-PEPPAS L: Novel vaginal drug release applications. Adv. Drug Del. Rev. (1993) 11:169–177.
   Web of Science ®Google Scholar
• RICHARDSON 31, BENEDETTI LM, RAMIRES, PA, CALLEGARO L: Evaluation of biodegradable polymeric micro-spheres for the vaginal administration of salmon caldtonin in the rat. Proc. 11th pbarm. technology confer-ence (1991): 32–48
   Google Scholar
• RICHARDSON JL, ILIUM L: The vaginal route of peptide and protein drug delivery. Adv. Drug Del. Rev. (1992) 8: 341–366
   Web of Science ®Google Scholar
• MARRIOTT C, MARTIN GP: Relevance of mucus. Advanced drug delivery. (1993) 11: R7
   Google Scholar
• KATZ DF, DUNMIRE EN: Cervical mucus - problems and opportunities for drug delivery via the vagina and cervix. Adv. Drug Del. Rev. (1993) 11: 385–401
   Web of Science ®Google Scholar
• MURATA Y, MAEDA T, MIYAMOTO E, KAWASHIMA 5: Preparation of chitosan-reinforced alginate gel beads - effects of chitosan on gel matrix erosion. Intern. J. Pharm. 96: 139–145
   Google Scholar
• KAMATH KR, PARK K: Biodegradable hydrogels in drug delivery. Adv. Drug Del. Rev. (1993) 11:59-84 Review
   Google Scholar
• DAHIYAT BI, HOSTIN E, POSADAS EM, LEONG KW: Synthesis and characterization of putrescine-based poly(phosphoester-urethanes). J. Btomaterials Sci. - Poly-mer Edition (1993) 4: 529–543
   PubMed Web of Science ®Google Scholar
• GANGADHARAM PRI, KAILASAM S, ASHTEKAR DR, WISEDL: Release of isoniazid for prolonged periods from a biodegradable polymer under several in vitro and simulated in vivo conditions and in animals. J. Control. Re (1993) 26: 87–98
   Google Scholar
• SONG CX, CUI XM, SCHINDLER A: Biodegradable copoly-mers based on p-dioxanone for medical application. Medical & Biological Engineering & Computing (1993) 31: Suppl. S147–S151
   Google Scholar
• VANDENMOOTER G, SAMYN C, KINGET R: Azo polymers for colon-specific drug delivery.2. Influence of the type of azo polymer on the degradation by intestinal mi-croflora. Intern. J. Pharm. (1993) 97: 133–139
   Google Scholar
• ASANO M, YOSHIDA M, OMICHE H, MASHIMO T, OKABE K, YUASA H, YAMANAKA H, MORIMOTO S, SAKAKMARA H: Biodegradable poly(DL-lactic add) formulations in a calcitonin delivery system. Biomaterials (1993)14: 797–799
   PubMed Web of Science ®Google Scholar
• MERKLI A, HELLER J, TABATABAY C, GURNY R: Synthesis and characterization of a new biodegradable semi-solid poly(ortho ester) for drug delivery systems. J. Biomate-rials Sci. - Polymer Edition 4: 505–516
   Google Scholar
• LI C, YANG DJ, ICUANG LR, WALLACE S: Polyamino acid microspheres - preparation, characterization and dis-tribution after intravenous injection in rats. Intern. J. Pharm. (1993) 94: 143–152
   Google Scholar
• ALONSO MJ, COHEN S, PARK TG, GUPTA RK, SEBER GR,LANGER R: Determinants of release rate of tetanus vaccine from polyester microspheres. Pharm. Res. (1993) 10: 945–953
   PubMed Web of Science ®Google Scholar
• 1WATA M, MCGINITY JW: Dissolution, stability, and mor-phological properties of conventional and multiphase poly(DL-lactic-co-glycolic add) microspheres contain-ing water-soluble compounds. Pharm. Res. (1993) 10: 1219–1227
   Google Scholar
• SANSDRAP P, MOES AJ: Influence of manufacturing pa-rameters on the size characteristics and the release profiles of nifedipine from poly(DL-lactide-co-gly-colide) microspheres. Intern.J. Pharm. (1993) 98: 157–164
   Web of Science ®Google Scholar
• ORIENTI I, ZECCHI V: Progesterone-loaded albumin mi-croparticles. J. Control. Rd (1993) 27: 1–7
   Web of Science ®Google Scholar
• LABR1E F, U SM, BELANGER A, COTE J, MERAND Y, LEPAGE M: Controlled release low dose medroxyprogesterone acetate (MPA) inhibits the development of mammary tumors induced by dimethyl-benz(a) anthracene in the rat breast. Cancer Res. Treat.(1993) 26: 253–265
   Google Scholar
• O'HAGAN DT, JEFFERY H, DAVIS SS: Long-term antibody responses in mice following subcutaneous immuniza-tion with ovalbumin entrapped in biodegradable mi-croparticles. Vaccine (1993)11: 965–969
   PubMed Web of Science ®Google Scholar
• ELDRIDGE JH, STAAS JK, CHEN DX, MARX PA, TICE TR, GILT FY RM: New advances in vaccine delivery systems. Seminars in Hematology (1993) 30 Suppl 4: 16–25
   PubMedGoogle Scholar
• MORRIS W, STEINHOFF MC, RUSSELL PK: Potential of polymer microencapsulation technology for vaccine Innovation. Vaccine (1994) 12: 5–11.
   PubMed Web of Science ®Google Scholar
• GOMBOTZ WR, PANKEY SC, BOUCHARD LS, RANCHALISJ, PUOLAKKAINEN P: Controlled release of TGF-13 (1) from a biodegradable matrix for bone regeneration. J. Biomaterials Sci. - Polymer Edition (1993) 5: 49–63
   PubMed Web of Science ®Google Scholar
• YAMAHARA H, LEE VHL: Drug metabolism in the oralcavity. Adv. Drug Del. Rev. (1993) 12: 25–39
   Google Scholar
• RATHBONE MJ: The oral cavity as a site for drug delivery.l. Adv. Drug Del. Rev. (1993) 12: R7–R8
   Google Scholar
• RATHBONE MJ, TUCKER IG: Mechanisms, barriers and pathways of oral mucosal drug permeation. Adv. Drug Del. Rev. (1993) 12: 41–60.
   Web of Science ®Google Scholar
• HO NFH: Biophysical kinetic modeling of buccal absorption. Adv. Drug Del. Rev. (1993) 12: 61–97
   Google Scholar
• HOOGSTRAATE AJ, BODDE HE: Methods for assessing the buccal mucosa as a route of drug delivery. Adv. Drug Del. Rev. (1993) 12: 99–125.
   Web of Science ®Google Scholar
• SQLTIER CA, WERTZ PW: Permeability and the patho physiology of oral mucosa. Adv. Drug Del. Rev. (1993) 12: 13–24 Review
   Google Scholar
• SENEL S, HOOGSTRAATE AJ, SPIES F, VERHOEF JC, JUNG-INGER HE, BODDE HE: Visualization of enhancing ef-fects of bile salts on buccal penetration. Eur. J. Moiphology (1993) 31: 13–24 Review
   Google Scholar
• SUTTON SC, LECLUYSE EL, ENGLE K, PIPKIN JD, FIX JA: Enhanced bioavailability of cefoxitin using pabnitoyl-Car nitine.2. Use of directly compressed tablet formula-tions in the rat and dog. Pharm. Res. (1993) 10: 1516–1520
   Google Scholar
• JIAN L, PO ALW: Effects of insulin and nasal absorptionenhancers on ciliary activity. Intern. J. Pharm. (1993) 95: 101–104
   Google Scholar
• JORGENSEN L, BECHGAARD E: Intranasal absorption ofangiopeptin - in vitro study of absorption and enzy-matic degradation. Intern. J. Pharm. (1993) 99: 165–172
   Google Scholar
• HOSOYA KI, KUBO H, NATSUME H, SUGIBAYASHI K, MORIMOTO Y, YAMASHITA S: The structural barrier of absorptive mucosae - site difference of the permeability of fluorescein isothiocyanate-labelled dextran in rab-bits. Biopharmaceutics & Drug Disposition (1993) 14: 685–695
   PubMed Web of Science ®Google Scholar
• SAYANI AP, CHUN IK, CHIEN YW: Transmucosal deliveryof leucine enkephalin - stabilization in rabbit enzyme extracts and enhancement of permeation through mu-cosae.j Pharm. Sci. (1993) 82: 1179–1185
   PubMedGoogle Scholar
• SCHIPPER NGM, VERHOEF JC, DELANNOY LM, ROMEIJN SG, BRAKKEE JH, WIEGANT VM, GISPEN V47H, MERKUS FWHM: Nasal administration of an ACTH(4-9) peptide analogue with dimethyl-beta-cyclodextrin as an ab-sorption enhancer - pharmacokinetics and dynamics. Brit. J. Pharmacol. (1993) 110: 1335–1340
   PubMedGoogle Scholar
• REARDON PM, WALL DA, HART TK, SMITH PL, GOCHOCO CH: lack of effect of ammonium glycyrrhizinate on the morphology of ovine nasal mucosa in vitro. Pharm. Res. (1993) 10: 1301–1307
   PubMedGoogle Scholar
• MAHJOUR M, MAUSER BE, RASHIDBAIGI ZA, FAWZI MB: Effects of propylene glycol diesters of caprylic and capric adds (Miglyol(r) 840) and ethanol binary sys-tems on in vitro skin permeation of drugs. Intern. J. Pharm. (1993) 95: 161–169
   Google Scholar
• UN SS, HO H, CHIEN YW: Development of a new nicotine transdermal delivery system - in vitro kinetics studies and clinical pharmacoldnetic evaluations in two ethnic groups. J. Control. Rel (1993) 26: 175–193
   Google Scholar
• HARADA S, TAKAHASHI Y, NAKAGAWA H: Transdermal administration of emedastine. Biol.& Pharm. Bull. (1993) 16: 884–888
   PubMed Web of Science ®Google Scholar
• MORIEARTY PL, THORNTON SL, BECKER RE: Transdermal patch delivery of acetylcholinesterase inhibitors. Meth-ods & Findings Exp. Clin. Pharmacol. (1993) 15:407–412
   PubMedGoogle Scholar
• MAN M, CHANG C, LEE PH, BROMAN CT, CLEARY GW: New Improved paddle method for determining the in vitro drug release profiles of transdermal delivery systems. J. Control. Rel (1993) 27: 59–68
   Web of Science ®Google Scholar
• HIRVONEN J, SUTINEN R, PARONEN P, URTTI A: Transder-mal penetration enhancers in rabbit pinna skin - Du-ration of action, skin irritation, and in vivo/in vitro comparison. Intern. J. Pharm. (1993) 99: 253–261
   Google Scholar
• GOVIL SK: Transdermal drug delivery devices: In: Drug delivery devices: Fundamentals &Applications. (1988). TYLE P (Ed.), 385–420
   Google Scholar
• FISCHER W: Trends in transdermal drug delivery sys-tems: In: Drug targeting and delivery (1002). JUNGINGER HE (Ed.), 190–202
   Google Scholar
• HADGRAFT J, WALTERS KA: Skin penetration enhancers: In: Drug Targeting and delivery (1992). JUNGINGER HE. (Ed.), 169–177
   Google Scholar
• SANTUS GC, BAKER RW: Transdermal enhancer patent literature. J. Contr. Rel. (1993) 25: 1–20
   Web of Science ®Google Scholar
• MICHN1AK BB, PLAYER MR, FUHRMAN LC, CHRISTENSEN CA, CHAPMAN JM, SOWELL JW: In vitro evaluation of a series of azone analogs as dermal penetration en-hancers. 2. (Thk)amides. Intern. J. Pharm. (1993) 94: 203–210
   Google Scholar
• KNOBLAUCH P, MOLL F: In vitro pulsatile and continu-ous transdermal delivery of buserelin by iontophore-sis. J. Control. Rel (1993) 26: 203–212
   Web of Science ®Google Scholar
• YOSHIDA R, SAKAI K, OKANO T, SAKURAI Y: Pulsatile drug delivery systems using hydrogels. J. Control. Rel (1993) 26: 203–212
   Google Scholar
• MAGGI L, CONTE U, GIUNCHEDI P, COLOMBO P: Press-coated tablets for the sequential pulsed administration of two different drugs. Intern.J. Pharm. (1993) 99: 173–179
   Web of Science ®Google Scholar
• XU X, LEE PI: Programmable drug delivery from an erodible assodation polymer system. Pharm. Res. (1993) 10: 1144–1152
   PubMed Web of Science ®Google Scholar
• KOST J: Pulsed and self-regulated drug delivery. CRC Press Inc Florida (1990)
   Google Scholar
• BAE YH, OKANO T, KIM SW: Insulin permeation through thermo-sensitive hydrogels. J. Controlled Release (1989) 9: 271
   Web of Science ®Google Scholar
• MIYAJIMA M, YOSHIDA M, SATO H, OMICHI H, KATAKAI R, HIGUCHI WI: Controlled release of 9-fi-D-arabinofura-nosylaclenine from thermo-responsive devices based on acryloyl-l-proline methyl ester. Intern. J. Pharm. (1993) 95: 153–160
   Google Scholar
• YUI N, OKANO T, SAKURAI Y: Photo-responsive degra-dation of heterogeneous hydrogels comprising crosslinked hyaluronk add and lipid microspheres for temporal drug delivery. j. Control. Rel (1993) 26: 141–145
   Web of Science ®Google Scholar
• TOMER R, FLORENCE AT: Photo-responsive hydrogels for potential responsive release applications. Intern. J. Pharmaceutic (1993)s 99: R5–R8
   Google Scholar
• EDELMAN ER, LANGER R: Optimization of release from magnetically controlled polymeric drug release de-vices. Biomaterials (1993) 14: 621–626
   PubMedGoogle Scholar
• KOST J: Ultrasound induced delivery of peptides. J. Control. Rel (1993) 24: 247–253
   Google Scholar
• HELLER J: Modulated release from drug delivery devices. Crit. Rev. Ther. Drug Carrier Sys. (1993)10: 253–305 .
   PubMed Web of Science ®Google Scholar
• ALBIN GW, HORBETT TA, MILLER SR, KICKER NL: Theo-retical and experimental studies of glucose sensitive membranes. J. Control. Rel. (1987) 6: 267–291
   Google Scholar
• SIEGAL RA, FIRESTONE BA: pH Dependent equilibrium swelling properties of hydrophobic polyelectrolyte gels. Macromolecules (1988) 21: 3254
   Web of Science ®Google Scholar
• FISCHEL-GHODSIAN F: Enzymatically controlled drug delivery. Proc. Natl. Acad. Sci. USA (1988) 85: 2403–2406
   PubMed Web of Science ®Google Scholar
• PAI CM, JACOBS H, BAE YH, KIM SW: Synthesis and characterization of soluble concanavalin-A oligomer. Biotechnology and bioengineering (1993) 41: 957–963
   PubMed Web of Science ®Google Scholar
• BROWNLEE M, CERAMI A: Glycosylated insulin com-plexed to con A. Diabetes (1983) 32: 499–504
   PubMed Web of Science ®Google Scholar
• JEONG SY et al.: Self regulating insulin delivery systems 1- synthesis and characterisation of glucosylated insu-lin. J. Control. Rel. (1984) 1: 57–66
   Google Scholar
• SATO S: Self regulating insulin delivery systems. 2. In vitro studies. J. Control. Rel. (1984) 1: 647–677
   Google Scholar
• AUBREELECAT A, DUBAN MC, DEMIGNOT S, DOMURADO M, FOURNIE P, DOMURADO D: Influence of barrier-crossing limitations on the amount of macromolecular drug taken up by its target. I Pharmacokinetics Biophann. (1993) 21: 75–98
   PubMedGoogle Scholar
• TSUJI A, TAMAI I, SAKATA A, TENDA Y, TERASAKI T: Restricted transport of cyclosporin-A across the blood brain barrier by a multidrug transporter, P-glycopro-tein. Biochem. PharmacoL (1993) 46: 1096–1099
   PubMed Web of Science ®Google Scholar
• MORIN KW, WIEBE LI, ICNAUS EE: Synthesis of brain-tar-geted 1-(2-deoxy-2-fluoro-13-D-ribofuranosyl)-(E)-5-(2-Jo dovinyOuracil coupled to a dihydropyridine reversible arrow pyridinium salt redox chemical-deliv-ery system. Carbohydrate Research (1993) 249: 109–116
   PubMedGoogle Scholar
• NARAYANI R, RAO ICP: Preparation, characterisation and is vitro stability of hydrophilic gelatin microspheres using a gelatin-methotrexate conjugate. Intern .J. Pharm (1993) 95: 85–91
   Google Scholar
• NAGY A, SZOKE B, SCHALLY AV: Selective coupling of methotrexate to peptide hormone carriers through a gamma-carboxamicie linkage of its giutamic acid moiety - benzotriazol- 1-yloxytris(dimethylamino)p hos-phonium hexafluorophosphate activation in salt cou-pling. Proc. Nat. Acad. Sci. USA 90: 6373-6376
   Google Scholar
• KWON GS, YOKOYAMA M, OKANO T, SAKURAI Y, KATAOICA K: Biodistribution of micelle-forming poly-mer-drug conjugates. Pharm. Res. (1993) 10: 970–974
   PubMed Web of Science ®Google Scholar
• KOPECEK J, DUNCAN R: Targetable polymeric drugs. J. Control. Rel. 6: 315–327
   Google Scholar
• VONBAEYER H, NEITZEL H, NUNDEL M, RIEDEL E, SCHUL-TIS HK: Covalent coupling of nucleoskles to low density lipoprotein (LDL) generates macrophage specific (drug)-carriers. Intern. J. Clin. PharmacoL Tber. Toxicol. (1993) 31: 382–386
   PubMedGoogle Scholar
• LUNDBERG BB: Evaluation of methods for complexing prednimustine to low density lipoprotein. Intern. I Pharm. (1993) 99: 275–283
   Google Scholar
• YAMAGUCHI T, TSURUMI H, KrIAMURA K, °TSUJI E, MIYAGAICI T, KOTANI T, TAKAHASHI T: Production, binding and cytotoxicity of human/mouse chimeric monoclonal antibody-neocarzinostatin conjugate. lap. J. Cancer Res. (1993) 84: 1190–1194
   PubMedGoogle Scholar
• OTSUJI E, YAMAGUCHI T, YAMAOKA N, KITAMURA K, YAMAGUCHI N, IMANISHI J, TAKAHASHI T: Increased antitumor effect of neocarzinostatin conjugated to monoclonal antibody-A7 on human pancreatic card-noma grafted in nude mice. Antibody Immunoconjugates Radiopharmaceut. (1993) 6: 177–183
   Google Scholar
• IWAHASHI T, OKOCHI E, ARIYOSHI K, WATABE H, AMANN E, MORI 5, TSURUO T, ONO K: Specific targeting and killing activities of anti-P-glycoprotein monoclonal antibody MRK16 directed against intrinsically mul-tidrug-resistant human colorectal carcinoma cell lines In the nude mouse model Cancer Res. (1993) 53: 5475–5482
   Google Scholar
• LEIB DA, OLIVO PD: Gene delivery to neurons - is herpes simplex virus the right tool for the job. Bioessays (1993) 15: 547–554.
   PubMedGoogle Scholar
• KONRAD MW: The immune system as a barrier to delivery of protein therapeutics biological barriers to protein delivery. Series: Pharm. Biotechnology (1993) 4: 409–437
   Google Scholar
• GABIZON A: Tailoring liposomes for cancer drug deliv-ery - From the bench to the clinic. Ann. Biol. Clin. (1993) 51: 811–813
   PubMed Web of Science ®Google Scholar
• KIM S: Liposomes as carriers of cancer chemotherapy - current status and future prospects drugs. (1993) 46: 618–638 Review
   Google Scholar
• DUZGUNES N, FELGNER PL: Intracellular delivery of nucleic acids and transcription factors by cationic liposomes. Membrane fusion techniques. Pt B Series: Meth-ods in enzymology (1993) 221: 303–306
   PubMed Web of Science ®Google Scholar
• STRAUBINGER RM: p11-Sensitive liposomes for delivery of macromolecules into cytoplasm of cultured ceBs. Membrane fusion techniques. Pt B series: Methods in enzy-mology (1993) 221: 361–376
   Google Scholar
• AMSELEM S, COHEN R, BARENHOLZ Y: In vitro tests to predict in vivo performance of liposomal dosage forms. Chem. Phys. Lipids (1993) 64: 219–237
   PubMed Web of Science ®Google Scholar
• PARNHAM MJ, WETZIG H: Toxicity screening of liposomes. Chem. Phys. Lipids (1993) 64: 263–274
   PubMed Web of Science ®Google Scholar
• GONDAL JA, PREUSS HG, SWARTZ R, RAHMAN A: Com-parative pharmacological, toxicological and antitu-moral evaluation of free and liposome-encapsulated cisplatin in rodents. Eur. J. Cancer (1993) 29A: 1536–1542
   PubMed Web of Science ®Google Scholar
• IGA K, OGAWA Y, TOGUCH1 H: Rates of systemic degradation and reticuloendothelial system (res) up-take of thermosensitive liposome encapsulating cis-platin in rats. Pharm. Res. 10: 1332-1337
   Google Scholar
• WEST. PE, ILLUM L, WASHINGTON, C, DAVIS SS: The effect of amphotericin b incorporation on the in vivo behav-iour of emulsions stabilised by a Tetronic or egg leci-thin. J. Pharm. Pharmacol (1989) 41: 79P
   PubMedGoogle Scholar
• BELAY T, HOSPENTHAL DR, ROGERS AL, PA111RSON MJ: Treatment of systemic candidiasis in a neutropenic murine model using itrununoglobulin-g bearing liposo-mal amphotericin-B. Mycopathologia (1993) 123: 9–17
   PubMedGoogle Scholar
• CLEMONS KV, STEVENS DA: Therapeutic efficacy of a liposomal formulation of amphotericin-b (AmBisome) against murine blastomycosis. j Antimicrob. Chemo. (1993) 32: 465–472
   PubMed Web of Science ®Google Scholar
• GIACCHINO R, GIAMBARTOLOMEI G, TASSO L, TIMMLLI A, CASTAGNOLA E, BRISIGOTTI M, MICALIZZI C: Treat-ment with liposomal amphotericin-11 of a child affected with drug-resistant visceral leishmanlasis. Trans. Roy. Soc.Trop. Med. Hyg. (1993) 87: 310
   PubMed Web of Science ®Google Scholar
• LAZANAS MC, TSEKES GA, PAPANDREOU S, HARHALAKIS N, SCANDALI A, NIKIFORAKIS E, SAROG LOU G: Liposomal amphotericin-B for leishtnaniasis treatment of AIDS patients unresponsive to antimonium compounds. AIDS 7: 1018-1019
   Google Scholar
• DIMARTINO L, RAIMONDI F, SCOTTI S, DAVIDSON RN, GRADONI L, GIACCHINO R: Efficacy and tolerability of liposomal amphotericin-b in Italian infants with vis-ceral lelshmaniasis. Trans. Roy. Soc.Trop.Med. Hyg. 87: 477
   Google Scholar
• RALPH ED, BARBER KR, GRANT CWM: Clinical experi-ence with multilamellar liposomal amphotericLall in patients with proven and suspected fungal infections. Scandinavian J. Infectious Diseases (1993) 25: 487–496
   PubMed Web of Science ®Google Scholar
• TORRECISNEROS J, VILLANUEVA JL, KINDELAN JM, JU-RADO R, SANCHEZGUIJO P: Successful treatment of antimony-resistant visceral leishmaniasis with liposo-mal amphotericin-B in patients infected with human immunodeficiency virus. Clin. Infect Dis. (1993) 17: 625–627
   PubMedGoogle Scholar
• BETAGERI GV, JENKINS SA, RAVIS WE: Drug delivery using antibody-liposome conjugates. Drug Dev. Ind. Pharm. (1993) 19: 2109–2116
   Web of Science ®Google Scholar
• WOODLE MC: Surface-modified liposomes - assessment and characterization for increased stability and pro-longed blood circulation. Chem. Phys. Lipids (1993) 64: 249–262
   PubMed Web of Science ®Google Scholar
• MOGHIMI SM, HEDEMAN H, MUIR IS, ILLUM L, DAVIS SS: An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen. Bloc/rim. Biophys. Acta (1993) 1157: 233–240
   PubMed Web of Science ®Google Scholar
• MOGHIMI SM, MUIR IS, ILLUM L, DAVIS SS, KOLBBACHOFEN V: Coating particles with a block co-polymer (poloxamine-908) suppresses opsonir•rion but permits the activity of dysopsonins in the serum. Biochim. Biophys. Acta (1993) 1179: 157–165
   PubMed Web of Science ®Google Scholar
• WU NZ, DA D, RUDOLL TL, NEEDHAM D, WHORTON AR, DEWHIRST MW: Increased tnicrovascular permeability contributes to preferential accumulation of stealth liposomes in tumor tissue. Cancer Res. (1993) 53: 3765–3770
   PubMed Web of Science ®Google Scholar
• ZSCHORNIG O, °MCI S: Effect of cholesterol, diacyl-glycerol and phosphatidylethanolamine on PEG 6000 Induced lipid mixing and surface dielectric constant of phosphatidylcholine vesicle. Gen. Phys. Biophys. (1993) 12: 259–269
   PubMedGoogle Scholar
• WILLIAMS SS, ALOSCO TR, MAYHEW E, LASIC DD, MARTIN FJ, BANKERT RB: Arrest of human lung tumor xenograft growth in severe combined imtnunodeficient mice us-ing doxorubicin encapsulated in sterkally stabilized liposomes. Cancer Res. (1993) 53: 3964–3967
   PubMed Web of Science ®Google Scholar
• ZALIPSKY S: Synthesis of an end-group functionalized polyethylene glycol-lipid conjugate for preparation of polymer-grafted liposomes. Bioconjugate Chem. (1993) 4: 296–299
   PubMed Web of Science ®Google Scholar
• NODA H, ICURONO M, OHISHI N, YAGI K: Stabilization of egg phosphatidykholine liposomes by the insertion of sulfatide. Biochim. Biophys. Acta (1993) 1153: 127–131
   PubMedGoogle Scholar
• VAAGE J, DONOVAN D, MAYHEW E, USTER P, WOODLE M: Therapy of mouse mammary carcinomas with vin-cristine and doxorubicin encapsulated in sterically sta-bilized liposomes. Intern. J. Cancer (1993) 54: 959–964
   PubMed Web of Science ®Google Scholar
• KADIR F: Intramuscular and subcutaneous drug delivery - encapsulation in liposomes and other methods to manipulate drug availability. Pharmacy World Sci. (1993) 15: 173–175
   Google Scholar
• TANG CS, SU JY, LI ZP, ZHANG LZ, YANG J, QI M, LIU FA, TANG J: Possibility of targeting treatment for ischemic heart disease with liposome. 1. Science in China. Series B - Chem. Life Sci. Earth Sci. (1993) 36: 590–598
   Google Scholar
• TANG CS, SU JY, LI ZP, ZHANG LZ, YANG J, QI M, LIU FA, TANG J: Possibility of targeting treatment for ischemic heart disease with liposome. 2. Science in China. Series B - Chem. Life Sci. Earth Sci. (1993) 36: 809–816
   Google Scholar
• GALLIGIONI E, QUAIA M, SPADA A, FAVARO D, SAN-TAROSA M, TALA.MINI R, MONFARDINI S: Activation of cytolytic activity in peripheral blood monocytes of renal cancer patients against noncultured autologous tumor cells. Intern. J. Cancer (1993) 55: 380–385
   Google Scholar
• MELISSEN PMB, VANVIANEN W, BIDJAI O, VANMARION M, BAKKERWOUDENBERG IAJM: Free versus liposome-en-capsulated muramyl tripeptide phosphatidylethano-lamide (MTPPE) and interferon-y (IFN-y) in experimental infection with Listeria monotytogenes. Biotherapy (1993) 6: 113–124
   PubMedGoogle Scholar
• ASANO T, KLEINERMAN ES: Liposome-encapsulated MTP-PE - A novel biologic agent for cancer therapy. J. Immunotherapy (1993) 14: 286–292
   PubMed Web of Science ®Google Scholar
• ASANO T, FUJIMAKI W, McWATTERS A, AN TH, MAT-SUSHIMA K, KLEINERMAN ES: Effect of adriamycin on liposomal muramyl tripeptides ability to up-regulate monocyte cytokine expression cancer immunology im-munotherapy. (1993) 37: 408–411
   Google Scholar
• FIDLER IJ, KLEINERMAN ES: Therapy of cancer metastasis by systemic activation of macrophages - from the bench to the clinic research in immunology. (1993) 144: 284–287
   Google Scholar
• DEAN T: Liposomes in allergy and immunology. Clin. Exp. All. (1993) 23: 557–563 Review
   Google Scholar
• VANROOIJEN N: Immunoadjuvant activities of liposomes - 2 different macrophage-mediated mecha-nisms. Vaccine (1993) 11: 1170
   PubMedGoogle Scholar
• GAY B, CARDOT JM, SCHNELL C, VANHOOGEVEST P, GYGAX D: Comparative pharmacokinetics of free mu-ramyl tripeptide phosphatidyl etbanolamine (MTP-PE) and liposomal MTP-PE. J. Pharm. Sci. (1993) 82: 997–1001
   PubMedGoogle Scholar
• STEVENS VC: Vaccine delivery systems - potential methods for use in antifertility vaccines. American J. Rep rod. Imm. (1993) 29: 176–188.
   PubMedGoogle Scholar
• ARAMAKI Y, TOMIZAWA H, HARA T, YACHT K, KIKUCHI H, TSUCHIYA S: Stability of liposomes in vitro and their uptake by rat Peyer's patches following oral administra-tion. Pharm. Res. (1993) 10:1228–1231
   PubMed Web of Science ®Google Scholar
• BENAHMEIDA ETS, GREGORIADIS G, POTTER CW, JEN-NINGS R: Immurtopotentiation of local and systemic hutnoral immune responses by ISCOMs, liposomes and FCA - role in protection against influenza-A in mice. Vaccine (1993) 11: 1302–1309
   PubMedGoogle Scholar
• WHITE K, KRZYCH U, GORDON DM, PORTER TG, RICHARDS RL, ALVING CR, DEAL CD, HOLLINGDALE M, SILVERMAN C, SYLVESTER DR, BALLOU WR, GROSS M: Induction of cytolytic and antibody responses using plasmodium falciparum repeatless circumsporozoite protein encapsulated in liposomes. Vaccine (1993) 11:
   Google Scholar
• MICHEL C, GROTH N, HERRLING T, RUDOLPH P, FUCHS J, KREUTER J, FREISLEBEN HJ: Penetration of spin-labeled retinoic add from liposomal preparations into the skin of SKII1 hairless mice measurement by EPR tomogra-phy. Intern. J. Pharm, 98: 131–139
   Google Scholar
• SCHMID MH, KORTING HC: Liposomes for atopic dry skin - the rationale for a promising approach. Clin. Investigator (1993) 71: 649–653
   PubMedGoogle Scholar
• FOLDVARI M, GESZItS A, MEZEI M, CARDINAL L, KOWAL-CZYK I, BEHL M: Topical liposomal local anesthetics - Design, optimirtion and evaluation of formulations. Drug Dev. Ind. Pharm. (1993) 19: 2499–2517
   Web of Science ®Google Scholar
• SVEINSSON SJ, HOLBROOK WP: Oral mucosal adhesive ointment containing liposomal corticosteroid. Intern .J. Pharm. (1993) 95: 105–109
   Web of Science ®Google Scholar
• PLEYER U, LUTZ S, JUSKO Dk7J, NGUYEN K, NARAWANE M, RUCKERT D, MONDINO BJ, LEE VHL: Ocular absorption of topically applied FK506 from liposomal and oil formulations in the rabbit eye. Invest. Ophthal. Vis. Sci. (1993)34: 2737–2742
   PubMed Web of Science ®Google Scholar
• WALDREP JC, SCHERER PW, KEYHANI K, KNIGHT V: Cyclosporin-A liposome aerosol - particle size and cal-culated respiratory deposition. Intern. J. Pharm. (1993) 97: 205–212
   Web of Science ®Google Scholar
• JULIANO RL: In: Targeted drug delivery (1991). Springer-Verlag New York 1991, Chapter 8
   Google Scholar
• KATO Y, HOSOKAWA T, HAYAKAWA E, ITO K: Influence of liposomes on tryptic digestion of insulin. 2. Biol. Pharm. Bull. (1993) 16: 740–744
   PubMed Web of Science ®Google Scholar
• HAEBERLIN B, RUBAS W, NOLEN I1W, FRIEND DR:in vitro evaluation of dexamethasone-f3-D-glucuronide for co-lon-specific drug delivery. Pharm. Res. (1993) 10: 1553–1562
   PubMed Web of Science ®Google Scholar
• FRENCH DL, MAUGER JW: Evaluation of the physico-chemical properties and dissolution characteristics of mesalamine - relevance to controlled intestinal drug delivery. Pharm. Res. (1993) 10: 1285–1290
   PubMed Web of Science ®Google Scholar
• KANE Y, RAMBAUD J, MAILLOLS H, LAGET JP, GAUDY D, DELONCA H: Technological evaluation of three enteric coating polymers. 1. With an insoluble. Drug dev. Ind. Pharm. (1993) 19: 2011–2020
   Web of Science ®Google Scholar
• ASHFORD M, FEU JT, ATEWOOD D, SHARMA H, WOOD-HEAD PJ: An in vivo investigation into the suitability of pH dependent polymers for colonic targeting. Intern. J. Pharm. (1993) 95: 193–199
   Web of Science ®Google Scholar
• PEE, I FAS R, KINGET R: Film-forming polymers for colonic drug delivery. 1. Synthesis and physical and chemi-cal properties of methyl derivatives of Eudragit-S. Intern.j. Pharm. (1993) 94: 125–134
   Google Scholar
• HOFMANN AF: Targeting drugs to the enterohepatic circulation: lessons from bile acids and other endobi-otics: In: Advances in Drug Delivery Systems (1986) . ANDER-SON JM, KIM SW (Eds.) 1: 3–12
   Google Scholar
• WATTS PJ, WILSON CG, DAVIES MC, MELIA CD: Radiola-belling of polymer microspheres for scintigraphic in-vestigations by neutron activation. 2. Effects of irradiation on the properties of Eudragit RS-sul-phasalazine microspheres. Intern. J. Pharrn. (1993) 98: 63–73
   Google Scholar
• WA11S PJ, WILSON CG, DAVIES MC, MELIA CD: Radiola-belling of polymer microspheres for sdntigraphic in-vestigations by neutron activation. 3. Changes in the physical properties of Eudragit RS-sulphapyridine microspheres from incorporating samarium oxide. In-tern. J. Pharm. (1993) 98: 75–82
   Google Scholar
• HARDY JG, HARVEY WI SPARROW RA, MARSHALL GB, STEED KP, MACARIOS M, WILDING IR: Localization of drug release sites from an oral sustained-release formu-lation of 5-ASA (Pentasa(R)) in the gastrointestinal tract using gamma-scintigraphy. J. Clin. Pharmacol. (1993) 33: 712–718
   PubMedGoogle Scholar